Actively Recruiting

Age: 18Years +
All Genders
ID07243132

Long-Term Responders in Metastatic Lung Cancer: Better Understanding for Better Management (LUNGEVITY STUDY)

Led by GFPC Investigation · Updated on 2026-04-27

1000

Participants Needed

46

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are studying patients who have lived for three years or more after being diagnosed with metastatic lung cancer and who are no longer receiving cytotoxic chemotherapy. The study aims to understand these patients' clinical characteristics, health status, socioeconomic impacts, quality of life, and their ability to return to work. This observational research focuses on both non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Participants will be observed over time without receiving experimental treatments. They will complete several questionnaires related to quality of life, anxiety, and depression at the start of the study, then at 6 and 12 months, and annually for up to five years. Their health and treatment history, including any ongoing therapies like immunotherapy or targeted therapy, will be recorded throughout the study. During the study, participants will continue their usual medical care and attend regular consultations as needed. Researchers will collect data through questionnaires and health evaluations to measure clinical characteristics, health status, socioeconomic factors, and psychological well-being. The main outcomes include baseline clinical data and repeated assessments over five years to better understand long-term survivorship after metastatic lung cancer diagnosis.

CONDITIONS

Brief Title

Long-Terms Responders in Metastatic Lung Cancer: Better Understanding for Better Management (Lungevity Study)

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient over 18 years old
  • Alive for more than three years after diagnosis with stage IV or stage III NSCLC or SCLC
  • Not receiving cytotoxic chemotherapy at the time of inclusion (immunotherapy, targeted therapy, or surveillance allowed)
  • Covered by the French National Health Insurance program or third-party health insurance
Not Eligible

You will not qualify if you...

  • Difficulty understanding French
  • Currently receiving cytotoxic chemotherapy
  • Under legal guardianship, curatorship, or tutorship
  • Insufficient cognitive ability to answer questions
  • Unable to collect data due to loss to follow-up or refusal
  • Refusal to allow collection of personal data

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Monitoring

Duration - Up to 5 years

Participants are observed over time with repeated questionnaires and assessments to better understand quality of life, anxiety, depression, and health status in long-term responders with metastatic lung cancer.

Visits at inclusion, 6 and 12 months after inclusion and yearly up to 5 years

Trial Site Locations

Total: 46 locations

1

CH du Pays d Aix

Aix-en-Provence, France, 13616

Actively Recruiting

2

CHU Angers

Angers, France, 49033

Not Yet Recruiting

3

Hôpital Henri Duffaut

Avignon, France, 84000

Actively Recruiting

4

CH Bastia

Bastia, France, 20200

Not Yet Recruiting

5

APHP Hôpital Avicennes

Bobigny, France, 93000

Actively Recruiting

6

CHU Morvan

Brest, France, 29200

Actively Recruiting

7

Hôpital Louis Pradel

Bron, France, 69500

Not Yet Recruiting

8

Pneumologie Centre François Baclesse

Caen, France, 14000

Not Yet Recruiting

9

Centre Hospitalier du Cotentin

Cherbourg, France, 50102

Actively Recruiting

10

CHU Hôpital Montpied

Clermont-Ferrand, France, 63000

Actively Recruiting

11

Oncologie CLCC Jean Perrin

Clermont-Ferrand, France, 63000

Not Yet Recruiting

12

Pneumologie Hospices Civils de Colmar

Colmar, France, 68024

Actively Recruiting

13

Pneumologie Centre Hospitalier Intercommunal de Créteil

Créteil, France, 94010

Actively Recruiting

14

Centre Hospitalier d'Elbeuf - Pneumologie

Elbeuf, France, 76503

Actively Recruiting

15

CH Eure-Seine

Évreux, France, 27015

Actively Recruiting

16

Grand Hôpital de l'Est Francilien - Site Marne la Vallée

Jossigny, France, 77600

Actively Recruiting

17

Centre Hospitalier Les Oudairies

La Roche-sur-Yon, France, 85000

Actively Recruiting

18

CH La Rochelle

La Rochelle, France, 17000

Actively Recruiting

19

Hôpital Robert Boulin

Libourne, France, 33505

Actively Recruiting

20

Hôpital de la Vallée

Longjumeau, France, 91160

Actively Recruiting

21

Hôpital du Scorff

Lorient, France, 56100

Actively Recruiting

22

Pneumologie Hôpital privé Jean Mermoz

Lyon, France, 69085

Not Yet Recruiting

23

Centre Léon Bérard

Lyon, France, 69373

Not Yet Recruiting

24

Hôpital Européen

Marseille, France, 130003

Not Yet Recruiting

25

Hôpital Nord - Oncologie Thoracique

Marseille, France

Actively Recruiting

26

GHEF Site de Meaux

Meaux, France, 77100

Actively Recruiting

27

CHRU de Nancy

Nancy, France, 54000

Not Yet Recruiting

28

CHU Nantes

Nantes, France, 44000

Not Yet Recruiting

29

Pneumologie Hôpital Cochin

Paris, France, 75014

Not Yet Recruiting

30

Hôpital Tenon

Paris, France, 75020

Not Yet Recruiting

31

Hôpital La Pitié-Salpêtrière

Paris, France, 75651

Actively Recruiting

32

Pneumologie Centre Hospitalier

Pau, France, 64000

Actively Recruiting

33

Centre Catalan d'Oncologie

Perpignan, France, 66000

Actively Recruiting

34

CHU Reims Hôpital Maison Blanche

Reims, France, 51000

Not Yet Recruiting

35

CHU Hôpital Ponchailloux

Rennes, France, 35033

Actively Recruiting

36

Hôpital Charles Nicolle

Rouen, France, 76031

Not Yet Recruiting

37

Hôpital Privé de la Loire

Saint-Etienne, France, 42000

Actively Recruiting

38

Pneumologie CHU St Etienne

Saint-Etienne, France, 42270

Actively Recruiting

39

CH des Vallées de l'Ariège

Saint-Jean-de-Verges, France, 09000

Actively Recruiting

40

CHU La Réunion Site Sud

Saint-Pierre, France, 97410

Not Yet Recruiting

41

CHU La Réunion Site Sud

Saint-Pierre, France, 97410

Actively Recruiting

42

CH de Saint Malo

St-Malo, France, 35000

Actively Recruiting

43

Hôpital d'Instruction des Armées Saint-Anne

Toulon, France, 83041

Actively Recruiting

44

Hôpital Larrey

Toulouse, France, 31059

Actively Recruiting

45

Oncologie CH Bretagne-Atlantique

Vannes, France, 56000

Actively Recruiting

46

Centre Hospitalier de Villefranche sur Saone

Villefranche-sur-Saône, France, 69655

Actively Recruiting

Loading map...

Research Team

A

Alice MOGENET

S

Soizic FERLANDIN

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

A Phase 1 First-In-Human Study of the Anti-CD73 IPH5301 Alon...

Metastatic Cancer

Actively Recruiting

1 location

A Feasibility Phase I Study of Therapeutic Drug Monitoring-B...

Locally Advanced Alveolar Soft Part Sarcoma

Actively Recruiting

1 location

Combination Therapies With Adagrasib, Pembrolizumab, and Che...

Advanced NSCLC

Actively Recruiting

166 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here